Society for Family Health (SFH), has decried rising cases of abortion among married women in Nigeria, attributing the development to the rise in inflation and love for their families. The nonprofit, non-political, non-governmental organization which intervenes in various health fields, added that many married women undertake to abort pregnancies without the knowledge of their husbands.
The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public notification on its website, 'Public Alert No.15/2023, regarding the recall of Caro White Skin Lightening Beauty Lotion by the European Union (EU) Rapid Alert System for Dangerous Non-Food Products (RAPEX). This action comes as the product fails to comply with the Cosmetic Products Regulation due to its high Kojic Acid concentration, surpassing the allowable maximum concentration of one percent. This conclusion was drawn by the EU Scientific Committee on Consumer Safety (SCCS).
The Phase II of the Human Papillomavirus (HPV) vaccination exercise will commence on 27th May, 2024 with Twenty-one states of the federation.
MeCure Industries, a pharmaceuticals company in Nigeria, has revealed it has secured approval from the National Agency for Food & Drug Administration and Control (NAFDAC) to launch production of the first locally manufactured alternative Amoxicillin-Clavulanic acid tablets, Amoxyclav 625mg. This was made known in a recent statement.“MeCure Industries completed its Beta-lactam plant (Amoxycillin and Clavulanic acid also known as Amoxyclav) and, in the first quarter of 2024, secured approval from NAFDAC to launch production of Amoxyclav 625mg tablets (the first locally manufactured alternative antibiotic tablets following the departure of major manufacturers of similar variants),” the statement said.
Scientists have created a vaccine that has the potential to protect against a broad range of coronaviruses, including varieties that are not yet known. The scientists from the University of Canbridge, the University of Oxford, and Caltech in the US are developing a novel approach called "proactive vaccinology" which aims to train the body's immune system to recognise several different coronaviruses. The vaccine is made by attaching harmless proteins from different coronaviruses to minuscule nanoparticles that are then injected to prime the body’s defences to fight the viruses should they ever invade. Because the vaccine trains the immune system to target proteins that are shared across many different types of coronavirus, the protection it induces is extremely broad, making it effective against known and unknown viruses in the same family.
The National Agency for the Control of AIDS, the Joint United Nations Programme on HIV/AIDS, and other development partners are set to optimise innovative HIV prevention and strategies for increased domestic funding towards community ownership and sustainability of HIV. The event which will be held between 7 and 9 May in Abuja, was contained in a statement issued on Friday and signed by the agency's public relations officer, Toyin Aderibige. The conference tagged "Accelerating HIV Prevention to End AIDS through Innovations and Community Engagement," aims at opening dialogue on optimistic innovative HIV prevention approaches towards achieving HIV epidemic control. It will also showcase a diverse array of sessions including dedicated tracks on youth empowerment, community engagement sessions, leadership discussions, plenary sessions, sponsored sessions, and special sessions.
